Skip to main content
SP5007,711.76-0.25%DOW53,559.99-0.02%NASDAQ26,402.42-0.52%BTC$77,728.00-3.40%ETH$2,441.16-2.91%GOLD$4,504.10-3.43%OIL$83.44-0.11%
Smart Investors Daily
Sign InSign Up Free
BAB, Inc. logo

OTC · BABB

BAB, Inc.

Consumer Defensive · Packaged Foods

$0.84

Up+$0.00 (+0.00%)

Updated Aug 29, 2026, 8:55 AM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
6.52M
P/E ratio
11.67
Dividend yield
7.14%
52-week range
$0.75 – $1.03
Volume
26.37K
Avg. volume
12.93K

Price performance

BABB price history

1M range · 0 trading sessions · Daily adjusted prices

BABB does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest BABB news

The latest Smart Investors Daily articles mentioning BABB.

Stock researchCompany · Overview

BABB research

Overview

Company profile and research snapshot.

Company profile

BAB INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 11, 2026

BAB, Inc. Reports Year-ended 11/30/25 Results

DEERFIELD, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- BAB, Inc. (OTCQB: BABB) announced its financial results for its fiscal year-ended November 30, 2025, reporting net income of $559,000, or $0.08 per share. For the year-ended November 30, 2025, BAB, Inc. had revenues of $3,439,000 and net income of $559,000, or $0.08 per share, versus revenues of $3,545,000 and net income of $525,000, or $0.07 per share, for the same period ending November 30, 2024. Income from operations for fiscal 2025 is $722,

defenseworld.net · Dec 8, 2025

Medifast (NYSE:MED) and BAB (OTCMKTS:BABB) Financial Survey

BAB (OTCMKTS:BABB - Get Free Report) and Medifast (NYSE: MED - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Profitability This table compares BAB and Medifast's net

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By